Advertisement

Topics

Concord Medical Holds Investor Day at Chang'an Hospital on May 31, 2012

05:31 EDT 29 Jun 2017 | PR Newswire

BEIJING, May 7, 2012 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and the operator of the largest network of radiotherapy and diagnostic imaging centers in China, announced today that it will hold an investor / analyst day at Chang'an Hospital, in Xi'an, China on May 31, 2012.

CCM recently announced the acquisition of a majority ownership stake in Chang'an Hospital. This represents one of the largest M&A transactions for a private hospital in China. The investor / analyst day will be an opportunity for management to showcase the hospital, as well as provide the market with an updated strategic and operating outlook for the company.

Dr. Jianyu Yang, Chairman and CEO said, "Recent reforms in the Chinese healthcare industry are providing investment opportunities for private investors, allowing them to play a major role in the future growth of the Chinese healthcare sector. We are confident that we can build Chang'an hospital into a leading international hospital with a focus on cancer treatment. We welcome all investors who are interested in private hospital development and cancer treatment market to participate in our investor and analyst day."

The event will include a tour of Chang'an hospital, management presentations and Q&A sessions.

The Company expects the transaction to receive the necessary government approvals and to close in the first half of 2012.  After closing, the Company will consolidate the financial results of Chang'an Hospital starting from Q3 of 2012.

About Concord Medical

Concord Medical Services Holdings Limited operates the largest network of radiotherapy and diagnostic imaging centers in China, measured by revenues and the number of centers in operation. As of December 31, 2011, the Company operated a network of 131 centers with 73 hospital partners that spanned 51 cities and 24 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, Concord Medical provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

Safe harbor statement

This news release may contain "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should," and "will" and similar expressions. These forward looking statements are based upon management's current views and expectations with respect to future events and are not a guarantee of future performance. Furthermore, these statements are, by their nature, subject to a number of risks and uncertainties that could cause actual performance and results to differ materially from those discussed in the forward-looking statements as a result of a number of factors. Such factors include the number of new radiotherapy and diagnostic imaging centers opened; the increase in the number of patients in existing centers; the establishment of specialty cancer hospitals; changes in the healthcare industry in China, including changes in the healthcare policies and regulations of the PRC government; technological or therapeutic changes affecting the field of cancer treatment and diagnostic imaging; and possible effects on consumers and hospitals, hospital construction, and suppliers, as a result of inflation and the Chinese government's policies and actions to control inflation. Further information regarding these and other risks is included in the Company's filings with the U.S. Securities and Exchange Commission at www.sec.gov. The Company does not assume any obligation to update any forward-looking statement, except as required by law.

Investor and Media Contacts:

Concord Medical Services

Mr. Tony Tian
tony.tian@concordmedical.com
(+86) 10 5957-5287

Solebury Communications

In China:
Ms. Cindy Li
cli@soleburyir.com
(+86) 10 6563-0288

In the United States
Mr. Richard Zubek
rzubek@soleburyir.com
(+1) 203-428-3230

SOURCE Concord Medical Services Holdings Limited

NEXT ARTICLE

More From BioPortfolio on "Concord Medical Holds Investor Day at Chang'an Hospital on May 31, 2012"

Quick Search
Advertisement
 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...